4.46 USD
↗ 0.07 (1.60%)AT CLOSE (11:59 AM EDT)
Immuneering Corporation Class A Common Stock
IMRXNASDAQ • USD
4.52
↗ 0.05 (1.23%)
POST MARKET (AS OF 07:45 PM EDT)
Post Market
AS OF 07:45 PM EDT
4.52
↗ 0.05 (1.23%)
Market: CLOSED
Immuneering Corporation Class A Common Stock (IMRX) trades at $4.46 per share. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, IMRX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 6, 2026.
Open?$4.64
High?$4.72
Low?$4.35
Prev. Close?$4.39
Volume?772.3K
Avg. Volume?1.1M
VWAP?$4.47
Rel. Volume?0.68x
Bid / Ask
Bid?$4.37 × 3.5K
Ask?$4.58 × 400
Spread?$0.21
Midpoint?$4.48
Valuation & Ratios
Market Cap?284.0M
Shares Out?64.7M
Float?55.9M
Float %?86.5%
P/E Ratio?N/A
P/B Ratio?1.49
EPS?-$0.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Themes
Employees
57
Market Cap
284.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-07-30
Address
245 MAIN STREET, SECOND FLOOR
CAMBRIDGE, MA 02142
Phone: 617-500-8080
CAMBRIDGE, MA 02142
Phone: 617-500-8080
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?12.75Safe
Confidence?45%Low
Short InterestSqueeze Risk
Short % of Float?27.19%Squeeze Risk
Short Interest?15.2M
Days to Cover?16.4
Free Float55.9M
Avg Daily Volume927.0K
Settlement Date2026-07-15
Financial Health
Current Ratio?19.47Strong
Quick Ratio?19.47Strong
Cash Ratio?5.09Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.49CHEAP▾
Peers100
S&P87
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-30.0%WEAK▾
S&P6
ROA?-28.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-56991132
Enterprise Value?$242.7M
Fundamentals ratios updated end of day